Anika Therapeutics reported $165.78M in Current Assets for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Assets Change
Acceleron Pharma XLRN:US $ 696.61M 21.16M
Adamas Pharmaceuticals ADMS:US 108M 7.65M
Agios Pharmaceuticals AGIO:US $ 1305.29M 397.28M
Anika Therapeutics ANIK:US $ 165.78M 11.98M
Arrowhead Research ARWR:US $ 384.6M 141.36M
Chemocentryx CCXI:US $ 293.38M 23.75M
Clovis Oncology CLVS:US $ 230.67M 65.69M
Dicerna Pharmaceuticals DRNA:US $ 589M 27.49M
Enanta Pharmaceuticals ENTA:US $ 319.02M 2.13M
Flexion Therapeutics FLXN:US $ 192.76M 8.64M
Halozyme Therapeutics HALO:US $ 1017.3M 17.55M
Heron Therapeutics HRTX:US $ 315.05M 51.77M
Immunogen IMGN:US $ 296.8M 22.41M
Insmed INSM:US $ 958.98M 79.21M
Integra Lifesciences IART:US $ 1.1B 71.4M
Intrexon XON:US $ 153.09M 3.59M
Karyopharm Therapeutics KPTI:US $ 241.58M 31.92M
Ligand Pharmaceuticals LGND:US $ 432.08M 21.18M
Macrogenics MGNX:US $ 334.7M 32.3M
Merit Medical Systems MMSI:US $ 463.44M 13.66M
Peregrine Pharmaceuticals PPHM:US $ 206.92M 6.14M
Rigel Pharmaceuticals RIGL:US $ 171.1M 13.09M
Sangamo Biosciences SGMO:US $ 447.4M 106.67M
Stryker SYK:US $ 9460M 428M
Surmodics SRDX:US $ 70.26M 23.86M
Veracyte VCYT:US $ 229.31M 142.04M
Xencor XNCR:US $ 329.63M 151.34M
Zimmer Biomet Holdings Inc ZBH:US $ 5.31B 44.4M